Dutton Richard P
University of Maryland School of Medicine, 22 South Greene Street, Baltimore, MD 21201, USA.
Anesthesiol Clin. 2007 Mar;25(1):23-34, viii. doi: 10.1016/j.atc.2006.11.007.
Treatment of hemorrhagic shock continues to evolve. Surgically, the concept of "damage control" has become the standard, with shorter operations focused on the control of life-threatening injuries. For the anesthesiologist, practice has changed, with a better understanding of the pathophysiology of shock, new techniques such as deliberate hypotension and perfusion-focused therapy, improved management of transfusion, and the advent of systemic hemostatic drug therapy. In this article, the author reviews each of these topics, and presents an integrated recommendation for early and late management of the patient in hemorrhagic shock.
失血性休克的治疗仍在不断发展。在外科手术方面,“损伤控制”理念已成为标准,手术时间缩短,重点在于控制危及生命的损伤。对于麻醉医生来说,实践也发生了变化,对休克病理生理学有了更好的理解,出现了如控制性低血压和灌注聚焦治疗等新技术,输血管理得到改善,全身性止血药物治疗也应运而生。在本文中,作者回顾了上述各个主题,并针对失血性休克患者的早期和晚期管理提出了综合建议。